Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Regulatory Actions
Teva Receives Favorable Court Decision Regarding Generic Lotrel; Novartis' Motion for Preliminary Injunction Denied
June 26th, 2007
Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced that the U.S. District Court for the District of New Jersey has vacated a temporary restraining order in effect since May 23, 2007 and denied a motion filed by Novartis for a preliminary injunction related to Teva's amlodipine besylate/ benazepril products, AB rated to Novartis' Lotrel(R). In reaching its opinion, the court found that Novartis was not likely to succeed on its allegations of infringement. Teva intends to resume commercial shipments of its amlodipine besylate/ benazepril products immediately. Teva's amlodipine besylate/ benazepril products were approved by the U.S. Food and Drug Administration on...
Source: Drug Law Weekly (2007-06-26)
|
